R-Pharm Keeping Biotech Local
Russia Emerging from Behind Iron Curtain with Innovation
By Michael Harris
Thursday, August 23, 2012
A string of first-ever events for Russia, including its official admittance to the World Trade Organization, plus committed government support to build a biopharma industry means the nation once known as the Kremlin may be in need of a more modern nickname as it transforms from an emerging market to one that could compete alongside the U.S., Japan and Europe.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.